Algernon Begins Screening Patients for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Aus..
Algernon Begins Screening Patients for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia VANCOUVER, British Columbia,...
Algernon Begins Screening Patients for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Aus..
Edgewater Wireless seeks $1.5M private placement to fund R&D, marketing push
Canadians Want to Seize Opportunity in Critical Minerals
Spyder Cannabis Announces Receipt of RSA ("Retail Store Authorization") for its Niagara Falls...
KABN North America Product Suite Ready for Consumer Rollout
© 2023 Frontier Merchant Capital Group. All Rights Reserved.